advertisement

---

Current Opinion in Molecular Therapeutics 1

Showing records 1 to 1 | Display all abstracts in Current Opinion in Molecular Therapeutics

9032 Technology evaluation: Lerdelimumab, Cambridge Antibody Technology
Cordeiro MF
Current Opinion in Molecular Therapeutics 2003; 5: 199-203

---